electroCore (ECOR) Cash & Equivalents Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -9.44% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 19.87% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -36.69% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 36.60% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 40.99% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.11% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.52% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -0.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.25% |
| 10 | electroCore | 92,394.96 | -8.79 Mn | 8.36 Mn | -25.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.62% |
| Dec 31, 2025 | -26.49% |
| Sep 30, 2025 | -28.67% |
| Jun 30, 2025 | -49.59% |
| Mar 31, 2025 | -49.81% |
| Dec 31, 2024 | -52.58% |
| Sep 30, 2024 | -49.38% |
| Jun 30, 2024 | -11.17% |
| Mar 31, 2024 | -4.69% |
| Dec 31, 2023 | 34.54% |
| Sep 30, 2023 | 52.00% |
| Jun 30, 2023 | -17.18% |
| Mar 31, 2023 | -8.65% |
| Dec 31, 2022 | 9.30% |
| Sep 30, 2022 | 48.96% |
| Jun 30, 2022 | 44.47% |
| Mar 31, 2022 | 62.58% |
| Dec 31, 2021 | 65.88% |
| Sep 30, 2021 | 13.10% |
| Jun 30, 2021 | -45.00% |
| Mar 31, 2021 | 81.32% |
| Dec 31, 2020 | -31.55% |
| Sep 30, 2020 | -25.81% |
| Jun 30, 2020 | 20.17% |